Levomilnacipran - CAS 175131-60-9
Catalog number: 175131-60-9
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
SSRIs
Description:
Levomilnacipran (brand name Fetzima) is an antidepressant approved for the treatment of major depressive disorder in the United States. It was developed by Forest Laboratories and Pierre Fabre Group, and was approved by the Food and Drug Administration in July 2013. Levomilnacipran is the levo- enantiomer of milnacipran, and has similar effects and pharmacology, acting as a serotonin-norepinephrine reuptake inhibitor (SNRI).
Publictions citing BOC Sciences Products
  • >> More
Purity:
0.98
Synonyms:
Levomilnacipran
MSDS:
Inquire
1.Effect of spinal monoaminergic neuronal system dysfunction on pain threshold in rats, and the analgesic effect of serotonin and norepinephrine reuptake inhibitors.
Tamano R1, Ishida M2, Asaki T1, Hasegawa M1, Shinohara S3. Neurosci Lett. 2016 Feb 26;615:78-82. doi: 10.1016/j.neulet.2016.01.025. Epub 2016 Jan 19.
Dysfunction in the central serotonin (5-HT) and norepinephrine (NE) systems cause depression and pain. Descending spinal pain modulatory pathways are important in the analgesic mechanisms of antidepressants, particularly serotonin and norepinephrine reuptake inhibitors (SNRIs). While many non-clinical studies have demonstrated the roles of central monoaminergic systems in pain, there is little evidence to illuminate the direct contribution of spinal descending pain modulatory systems independently of depressive-like behavior. To examine the effects of dysfunction of spinal monoaminergic systems on pain sensitivity, we established a rat chronic pain model by administering lumbar-intrathecal reserpine to minimize its influence on brain. Lumbar-intrathecal reserpine evoked persistent mechanical hypersensitivity and corresponding reductions in spinal 5-HT and NE concentrations (from 767.2 to 241.6ng/g and from 455.9 to 41.7ng/g, respectively after reserpine 30nmol).
2.Electroacupuncture Enhances the Antiallodynic and Antihyperalgesic Effects of Milnacipran in Neuropathic Rats.
Li C1, Ji BU, Kim Y, Lee JE, Kim NK, Kim ST, Koo S. Anesth Analg. 2016 May;122(5):1654-62. doi: 10.1213/ANE.0000000000001212.
BACKGROUND: Milnacipran, a selective serotonin/norepinephrine-reuptake inhibitor, has been shown to elicit a beneficial effect in various models of neuropathic pain. Previously, we reported that repetitive electroacupuncture (EA) significantly ameliorates neuropathic pain induced by L5 spinal nerve ligation (SNL). In the present study, we sought to determine whether a single treatment with EA produces analgesia and whether EA in combination with a subeffective dosage of milnacipran exhibits an additive effect in SNL rats.
3.Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH1, Song GG2. Rheumatol Int. 2016 May;36(5):663-72. doi: 10.1007/s00296-016-3468-5. Epub 2016 Mar 21.
The aim of this study was to assess the relative efficacy and tolerability of duloxetine, pregabalin, and milnacipran at the recommended doses in patients with fibromyalgia. Randomized controlled trials (RCTs) examining the efficacy and safety of duloxetine 60 mg, pregabalin 300 mg, pregabalin 150 mg, milnacipran 200 mg, and milnacipran 100 mg compared to placebo in patients with fibromyalgia were included in this Bayesian network meta-analysis. Nine RCTs including 5140 patients met the inclusion criteria. The proportion of patients with >30 % improvement from baseline in pain was significantly higher in the duloxetine 60 mg, pregabalin 300 mg, milnacipran 100 mg, and milnacipran 200 mg groups than in the placebo group [pairwise odds ratio (OR) 2.33, 95 % credible interval (CrI) 1.50-3.67; OR 1.68, 95 % CrI 1.25-2.28; OR 1.62, 95 % CrI 1.16-2.25; and OR 1.61; 95 % CrI 1.15-2.24, respectively]. Ranking probability based on the surface under the cumulative ranking curve (SUCRA) indicated that duloxetine 60 mg had the highest probability of being the best treatment for achieving the response level (SUCRA = 0.
4.Evidence-Based Pharmacologic Approaches for Chronic Orofacial Pain.
Clark G. J Calif Dent Assoc. 2015 Nov;43(11):643-54.
For neuropathic pain, the three medications to use are gabapentinoids, tricyclic antidepressants and serotonin norepinephrine reuptake inhibitors plus topical anesthetics. Beta-blockers, tricyclic antidepressants and anti-epileptic drugs are effective preventive medications for daily migraine headaches. The three FDA-approved drugs for fibromyalgia, pregabalin, duloxetine and milnacipran, are not robust. For osteoarthritis, nonsteroidal anti-inflammatories have good efficacy, and when gastritis contraindicates them, corticosteroid injections are helpful.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related SSRIs Products


CAS 93413-69-5 Venlafaxine

Venlafaxine
(CAS: 93413-69-5)

Venlafaxine is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class, but it has been referred to as a serotonin-norepinephrine-dopa...

CAS 101152-94-7 Milnacipran HCl

Milnacipran HCl
(CAS: 101152-94-7)

Milnacipran inhibits both norepinephrine transporter (NET) and norepinephrine transporter (SERT) with IC50 of 77 nM and 420 nM, respectively. Milnacipran at hig...

CAS 1229-29-4 Doxepin Hydrochloride

Doxepin Hydrochloride
(CAS: 1229-29-4)

Highly potent H1 histamine receptor antagonist (Kd = 310 pM) and tricyclic antidepressant. Also binds to the H4 histamine receptor (pKi = 6.79).

CAS 54739-18-3 Fluvoxamine

Fluvoxamine
(CAS: 54739-18-3)

Fluvoxamine is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor. It is effective in inhibiting 5-ht uptake by blo...

CAS 99300-78-4 Venlafaxine hydrochloride

Venlafaxine hydrochloride
(CAS: 99300-78-4)

Venlafaxine hydrochloride is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class, but it has been referred to as a serotonin-norep...

CAS 136434-34-9 Duloxetine Hydrochloride

Duloxetine Hydrochloride
(CAS: 136434-34-9)

Duloxetine Hydrochloride is a serotonin-norepinephrine reuptake inhibitor with Ki of 4.6 nM, used for treatment of major depressive disorder and generalized anx...

CAS 128196-01-0 Escitalopram

Escitalopram
(CAS: 128196-01-0)

Escitalopram, the S-enantiomer of citalopram, belongs to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). Escitalopram...

CAS 61718-82-9 Fluvoxamine maleate

Fluvoxamine maleate
(CAS: 61718-82-9)

Fluvoxamine maleate is a selective serotonin (5-HT) reuptake inhibitor (SSRI) and sigma-1 receptor agonist.

CAS 125494-59-9 Sibutramine hydrochloride monohydrate

Sibutramine hydrochloride monohydrate
(CAS: 125494-59-9)

A serotonin and noradrenaline reuptake inhibitor (SNR). Decreases calorie intake and increases energy expenditure.

CAS 175131-60-9 Levomilnacipran

Levomilnacipran
(CAS: 175131-60-9)

Levomilnacipran (brand name Fetzima) is an antidepressant approved for the treatment of major depressive disorder in the United States. It was developed by Fore...

CAS 19794-93-5 Trazodone

Trazodone
(CAS: 19794-93-5)

Trazodone, a phenylpiperazine compound, acts as a serotonin uptake inhibitor with antianxiety (anxiolytic) and sleep-inducing (hypnotic) effects.

CAS 79559-97-0 Sertraline HCl

Sertraline HCl
(CAS: 79559-97-0)

Sertraline HCl is a 5-HT antagonist with Ki of 13 nM.

CAS 56296-78-7 Fluoxetine hydrochloride

Fluoxetine hydrochloride
(CAS: 56296-78-7)

Fluoxetine is a selective serotonin-reuptake inhibitor (SSRI) at the neuronal membrane, used in the treatment of depression.

CAS 110429-35-1 Paroxetine hydrochloride hemihydrate

Paroxetine hydrochloride hemihydrate
(CAS: 110429-35-1)

Paroxetine hydrochloride hemihydrate is a antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs).

CAS 24853-80-3 Azaphen

Azaphen
(CAS: 24853-80-3)

An antidepressant having effects on the autonomic nervous system; the drug is especially effective for mild and moderate depressions and a combination of Azaphe...

CAS 129938-20-1 Dapoxetine hydrochloride

Dapoxetine hydrochloride
(CAS: 129938-20-1)

Dapoxetine HCl is a short-acting novel selective serotonin reuptake inhibitor.

CAS 63302-99-8 Azaphen dihydrochloride monohydrate

Azaphen dihydrochloride monohydrate
(CAS: 63302-99-8)

Azaphen dihydrochloride monohydrate is a potent inhibitor of the reuptake of serotonin. It is a tricyclic antidepressant (TCA) approved in Russia for the treatm...

CAS 54910-89-3 Fluoxetine

Fluoxetine
(CAS: 54910-89-3)

class. It delays the reuptake of serotonin, resulting in serotonin persisting longer when it is released. It may also produce some of its effects via its weak 5...

CAS 219861-08-2 Escitalopram Oxalate

Escitalopram Oxalate
(CAS: 219861-08-2)

Escitalopram Oxalate also known by the brand names Lexapro and Cipralex among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) ...

CAS 386750-22-7 Desvenlafaxine Succinate

Desvenlafaxine Succinate
(CAS: 386750-22-7)

Desvenlafaxine Succinate is a new serotonin (5-HT) transporter and norepinephrine (NE) transporter reuptake inhibitor with Ki of 40.2 nM and 558.4 nM respective...

Chemical Structure

CAS 175131-60-9 Levomilnacipran

Quick Inquiry

Verification code

Featured Items